Skip to main content
SpringerLink
Log in

Overview of Hepatitis Viruses and Cancer

  • Chapter
  • First Online:
Cancer Associated Viruses

Part of the book series: Current Cancer Research ((CUCR))

  • 1248 Accesses

Abstract

The major etiology of hepatocellular carcinoma (HCC), the primary cancer of the liver, is chronic infection with either hepatitis B virus (HBV) or hepatitis C virus (HCV), as illustrated in Fig. 21.1. This chapter summarizes these viruses and the cancer with which they are associated, from the virological and molecular perspective. More detail about each virus is provided in subsequent chapters.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Alpert ME, Uriel J, de Nechaud B (1968) Alpha-1 fetoglobulin in the diagnosis of human hepatoma. N Engl J Med 278(18):984–986

    PubMed  CAS  Google Scholar 

  • Ambros V (2004) The functions of animal microRNAs. Nature 431(7006):350–355

    PubMed  CAS  Google Scholar 

  • Aoyagi Y, Isokawa O, Suda T, Watanabe M, Suzuki Y, Asakura H (1998) The fucosylation index of alpha-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma. Cancer 83(10):2076–2082

    PubMed  CAS  Google Scholar 

  • Aravalli RN, Steer CJ, Cressman EN (2008) Molecular mechanisms of hepatocellular carcinoma. Hepatology 48(6):2047–2063

    PubMed  CAS  Google Scholar 

  • Azechi H, Nishida N, Fukuda Y, Nishimura T, Minata M, Katsuma H, Kuno M, Ito T, Komeda T, Kita R, Takahashi R, Nakao K (2001) Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas. Oncology 60(4):346–354

    PubMed  CAS  Google Scholar 

  • Bai F, Nakanishi Y, Takayama K, Pei XH, Inoue K, Harada T, Izumi M, Hara N (2003) Codon 64 of K-ras gene mutation pattern in hepatocellular carcinomas induced by bleomycin and 1-nitropyrene in A/J mice. Teratog Carcinog Mutagen Suppl 1:161–170

    PubMed  Google Scholar 

  • Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297

    PubMed  CAS  Google Scholar 

  • Beck J, Nassal M (2007) Hepatitis B virus replication. World J Gastroenterol 13(1):48–64

    PubMed  CAS  Google Scholar 

  • Bhattacharyya SN, Habermacher R, Martine U, Closs EI, Filipowicz W (2006) Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 125(6):1111–1124

    PubMed  CAS  Google Scholar 

  • Bill CA, Summers J (2004) Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration. Proc Natl Acad Sci USA 101(30):11135–11140

    PubMed  CAS  Google Scholar 

  • Block TM, Mehta AS, Fimmel CJ, Jordan R (2003) Molecular viral oncology of hepatocellular carcinoma. Oncogene 22(33):5093–5107

    PubMed  CAS  Google Scholar 

  • Block TM, Guo H, Guo JT (2007) Molecular virology of hepatitis B virus for clinicians. Clin Liver Dis 11(4):685–706, vii

    PubMed  Google Scholar 

  • Block TM, Marrero J, Gish RG, Sherman M, London WT, Srivastava S, Wagner PD (2008) The degree of readiness of selected biomarkers for the early detection of hepatocellular carcinoma: notes from a recent workshop. Cancer Biomark 4(1):19–33

    PubMed  CAS  Google Scholar 

  • Bouchard MJ, Schneider RJ (2004) The enigmatic X gene of hepatitis B virus. J Virol 78(23):12725–12734

    PubMed  CAS  Google Scholar 

  • Bouchard MJ, Wang LH, Schneider RJ (2001) Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science 294(5550):2376–2378

    PubMed  CAS  Google Scholar 

  • Bouchard MJ, Puro RJ, Wang L, Schneider RJ (2003) Activation and inhibition of cellular calcium and tyrosine kinase signaling pathways identify targets of the HBx protein involved in hepatitis B virus replication. J Virol 77(14):7713–7719

    PubMed  CAS  Google Scholar 

  • Branda M, Wands JR (2006) Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma. Hepatology 43(5):891–902

    PubMed  CAS  Google Scholar 

  • Brechot C (1987) Hepatitis B virus (HBV) and hepatocellular carcinoma. HBV DNA status and its implications. J Hepatol 4(2):269–279

    PubMed  CAS  Google Scholar 

  • Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35(3):421–430

    PubMed  CAS  Google Scholar 

  • Buamah PK, Gibb I, Bates G, Ward AM (1984) Serum alpha fetoprotein heterogeneity as a means of differentiating between primary hepatocellular carcinoma and hepatic secondaries. Clin Chim Acta 139(3):313–316

    PubMed  CAS  Google Scholar 

  • Budhu A, Forgues M, Ye QH, Jia HL, He P, Zanetti KA, Kammula US, Chen Y, Qin LX, Tang ZY, Wang XW (2006) Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell 10(2):99–111

    PubMed  CAS  Google Scholar 

  • Chang J, Taylor JM (2008) miR-122 and liver disease. In: Altman S, Victor A, Appasani K (eds) microRNAs: from basic science to disease biology. Cambridge University Press, Cambridge, pp 338–349

    Google Scholar 

  • Chang J, Nicolas E, Marks D, Sander C, Lerro A, Buendia MA, Xu C, Mason WS, Moloshok T, Bort R, Zaret KS, Taylor JM (2004) miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol 1(2):106–113

    PubMed  CAS  Google Scholar 

  • Chen HS, Kaneko S, Girones R, Anderson RW, Hornbuckle WE, Tennant BC, Cote PJ, Gerin JL, Purcell RH, Miller RH (1993) The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol 67(3):1218–1226

    PubMed  CAS  Google Scholar 

  • Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH (2006a) Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295(1):65–73

    PubMed  CAS  Google Scholar 

  • Chen G, Lin W, Shen F, Iloeje UH, London WT, Evans AA (2006b) Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study. Am J Gastroenterol 101(8):1797–1803

    PubMed  Google Scholar 

  • Chisari FV, Ferrari C (1995) Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13:29–60

    PubMed  CAS  Google Scholar 

  • Chisari F, Klopchin K, Morijama T, Pasquinelli C, Dunsford HA, Sell S, Pinkert CA, Brinster RL, Palmiter RD (1989) Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59:1145–1156

    PubMed  CAS  Google Scholar 

  • Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244(4902):359–362

    PubMed  CAS  Google Scholar 

  • Choudhari SR, Khan MA, Harris G, Picker D, Jacob GS, Block TM, Shailubhai K (2007) Deactivation of Akt and STAT-3 signaling promotes apoptosis, inhibits proliferation and enhances sensitivity of HCC cells to an anti-cancer agent, Atiprimod. Mol Cancer Ther 6(1):112–121

    PubMed  CAS  Google Scholar 

  • Colnot S, Decaens T, Niwa-Kawakita M, Godard C, Hamard G, Kahn A, Giovannini M, Perret C (2004) Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas. Proc Natl Acad Sci USA 101(49):17216–17221

    PubMed  CAS  Google Scholar 

  • Coulouarn C, Factor VM, Andersen JB, Durkin ME, Thorgeirsson SS (2009) Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 28(40):3526–3536

    PubMed  CAS  Google Scholar 

  • Davis GL, Dempster J, Meler JD, Orr DW, Walberg MW, Brown B, Berger BD, O’Connor JK, Goldstein RM (2008) Hepatocellular carcinoma: management of an increasingly common problem. Proc (Bayl Univ Med Cent) 21(3):266–280

    Google Scholar 

  • Dejean A, Bougueleret L, Grzeschik KH, Tiollais P (1986) Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma. Nature 322(6074):70–72

    PubMed  CAS  Google Scholar 

  • Di Bisceglie AM, Carithers RL Jr, Gores GJ (1998) Hepatocellular carcinoma. Hepatology 28(4):1161–1165

    PubMed  Google Scholar 

  • Di Bisceglie AM, Lyra AC, Schwartz M, Reddy RK, Martin P, Gores G, Lok AS, Hussain KB, Gish R, Van Thiel DH, Younossi Z, Tong M, Hassanein T, Balart L, Fleckenstein J, Flamm S, Blei A, Befeler AS (2003) Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol 98(9):2060–2063

    PubMed  Google Scholar 

  • Donato F, Boffetta P, Puoti M (1998) A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 75(3):347–354

    PubMed  CAS  Google Scholar 

  • El-Serag HB, Mason AC, Key C (2001) Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology 33:62–65

    PubMed  CAS  Google Scholar 

  • El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132(7):2557–2576

    PubMed  CAS  Google Scholar 

  • Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M, McKay R, Subramaniam A, Propp S, Lollo BA, Freier S, Bennett CF, Bhanot S, Monia BP (2006) miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3(2):87–98

    PubMed  CAS  Google Scholar 

  • Evans MJ, Rice CM, Goff SP (2004) Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication. Proc Natl Acad Sci USA 101(35):13038–13043

    PubMed  CAS  Google Scholar 

  • Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M, Wolk B, Hatziioannou T, McKeating JA, Bieniasz PD, Rice CM (2007) Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446(7137):801–805

    PubMed  CAS  Google Scholar 

  • Farazi PA, DePinho RA (2006) Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6(9):674–687

    PubMed  CAS  Google Scholar 

  • Fourel G, Trepo C, Bougueleret L, Henglein B, Ponzetto A, Tiollais P, Buendia MA (1990) Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours. Nature 347(6290):294–298

    PubMed  CAS  Google Scholar 

  • Fukutomi T, Zhou Y, Kawai S, Eguchi H, Wands JR, Li J (2005) Hepatitis C virus core protein stimulates hepatocyte growth: correlation with upregulation of wnt-1 expression. Hepatology 41(5):1096–1105

    PubMed  CAS  Google Scholar 

  • Guo H, Zhou T, Jiang D, Cuconati A, Xiao GH, Block TM, Guo JT (2007) Regulation of hepatitis B virus replication by the phosphatidylinositol 3-kinase-akt signal transduction pathway. J Virol 81(18):10072–10080

    PubMed  CAS  Google Scholar 

  • Hassan M, Selimovic D, Ghozlan H, Abdel-kader O (2009) Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathways. Hepatology 49(5):1469–1482

    PubMed  CAS  Google Scholar 

  • Hickman ES, Helin K (2002) The regulation of APAF1 expression during development and tumourigenesis. Apoptosis 7(2):167–171

    PubMed  CAS  Google Scholar 

  • Hildt E, Munz B, Saher G, Reifenberg K, Hofschneider PH (2002) The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice. EMBO J 21(4):525–535

    PubMed  CAS  Google Scholar 

  • Hoofnagle JH (2004) Hepatocellular carcinoma: summary and recommendations. Gastroenterology 127(5 Suppl 1):S319–S323

    PubMed  Google Scholar 

  • Hoofnagle JH, Di Bisceglie AM (1997) The treatment of chronic viral hepatitis. N Engl J Med 336(5):347–356

    PubMed  CAS  Google Scholar 

  • Hoshida Y, Nijman SM, Kobayashi M, Chan JA, Brunet JP, Chiang DY, Villanueva A, Newell P, Ikeda K, Hashimoto M, Watanabe G, Gabriel S, Friedman SL, Kumada H, Llovet JM, Golub TR (2009) Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res 69(18):7385–7392

    PubMed  CAS  Google Scholar 

  • Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK (eds). SEER Cancer Statistics Review, 1975–2008, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2008/, based on November 2010 SEER data submission, posted to SEER web site, 2011. NCI: Surveillance Epidmiology and End Results

  • Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, Lai MD, Chang WT, Huang W (2004) Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 25(10):2023–2032

    PubMed  CAS  Google Scholar 

  • Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T, Group, M (2001) Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 357(9262):1069–1075

    PubMed  CAS  Google Scholar 

  • Jackson RJ, Standart N (2007) How do microRNAs regulate gene expression? Sci STKE 367:re1

    Google Scholar 

  • Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309(5740):1577–1581

    PubMed  CAS  Google Scholar 

  • Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, Frankel W, Jacob ST, Ghoshal K (2006) Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 99(3):671–678

    PubMed  CAS  Google Scholar 

  • Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, Kauppinen S, Orum H (2010) Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327(5962):198–201

    PubMed  CAS  Google Scholar 

  • Llovet JM (2007) Clinical and molecular classification of hepatocellular carcinoma. Liver Transpl 13(11 Suppl 2):S13–S16

    PubMed  Google Scholar 

  • Lok A, McMahon B (2001) Chronic hepatitis B. Hepatology 34(6):1225–1241

    PubMed  CAS  Google Scholar 

  • Lok AS, Heathcote EJ, Hoofnagle JH (2001) Management of hepatitis B: 2000 – summary of a workshop. Gastroenterology 122(7):2092–2093

    Google Scholar 

  • Macdonald A, Harris M (2004) Hepatitis C virus NS5A: tales of a promiscuous protein. J Gen Virol 85(Pt 9):2485–2502

    PubMed  CAS  Google Scholar 

  • Majumder M, Ghosh AK, Steele R, Ray R, Ray RB (2001) Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner. J Virol 75(3):1401–1407

    PubMed  CAS  Google Scholar 

  • Marrero JA (2006) Hepatocellular carcinoma. Curr Opin Gastroenterol 22(3):248–253

    PubMed  Google Scholar 

  • Marrero JA, Feng Z, Wang Y, Nguyen MH, Befeler AS, Roberts LR, Reddy KR, Harnois D, Llovet JM, Normolle D, Dalhgren J, Chia D, Lok AS, Wagner PD, Srivastava S, Schwartz M (2009) Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology 137(1):110–118

    PubMed  CAS  Google Scholar 

  • McMahon BJ, Bulkow L, Harpster A, Snowball M, Lanier A, Sacco F, Dunaway E, Williams J (2000) Screening for Hepatocellular Carcinoma in Alaska Natives Infected with Chronic Hepatitis B: A 16-Year Population-Based Study. Hepatology 32:842–846

    PubMed  CAS  Google Scholar 

  • Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133(2):647–658

    PubMed  CAS  Google Scholar 

  • Miller BA, Chu KC, Hankey BF, Ries LAG (2008) Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the US. Cancer Causes Control 19(3):227–256

    PubMed  CAS  Google Scholar 

  • Minouchi K, Kaneko S, Kobayashi K (2002) Mutation of p53 gene in regenerative nodules in cirrhotic liver. J Hepatol 37(2):231–239

    PubMed  CAS  Google Scholar 

  • Miyanari Y, Atsuzawa K, Usuda N, Watashi K, Hishiki T, Zayas M, Bartenschlager R, Wakita T, Hijikata M, Shimotohno K (2007) The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 9(9):1089–1097

    PubMed  CAS  Google Scholar 

  • Moraleda G, Saputelli J, Aldrich CE, Averett D, Condreay L, Mason WS (1997) Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus. J Virol 71(12):9392–9399

    PubMed  CAS  Google Scholar 

  • Myers RP, Benhamou Y, Imbert-Bismut F, Thibault V, Bochet M, Charlotte F, Ratziu V, Bricaire F, Katlama C, Poynard T (2003) Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients. AIDS 17(5):721–725

    PubMed  CAS  Google Scholar 

  • Nakamoto Y, Guidotti LG, Kuhlen CV, Fowler P, Chisari FV (1998) Immune pathogenesis of hepatocellular carcinoma. J Exp Med 188(2):341–350

    PubMed  CAS  Google Scholar 

  • Newbold JE, Xin H, Tencza M, Sherman G, Dean J, Bowden S, Locarnini S (1995) The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J Virol 69(6):3350–3357

    PubMed  CAS  Google Scholar 

  • Parkin DM (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118(12):3030–3044

    PubMed  CAS  Google Scholar 

  • Pekow JR, Bhan AK, Zheng H, Chung RT (2007) Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer 109(12):2490–2496

    PubMed  Google Scholar 

  • Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, Terris B, Mazzaferro V, Lowe SW, Croce CM, Dejean A (2010) miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci USA 107(1):264–269

    PubMed  CAS  Google Scholar 

  • Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, de Jong YP, Rice CM (2009) Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457(7231):882–886

    PubMed  CAS  Google Scholar 

  • Poynard T, Imbert-Bismut F, Ratziu V, Chevret S, Jardel C, Moussalli J, Messous D, Degos F (2002) Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J Viral Hepat 9(2):128–133

    PubMed  CAS  Google Scholar 

  • Ray RB, Steele R, Meyer K, Ray R (1997) Transcriptional repression of p53 promoter by hepatitis C virus core protein. J Biol Chem 272(17):10983–10986

    PubMed  CAS  Google Scholar 

  • Reed KE, Rice CM (2000) Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 242:55–84

    PubMed  CAS  Google Scholar 

  • Roncalli M, Borzio M, Di Tommaso L (2007) Hepatocellular dysplastic nodules. Hepatol Res 37(Suppl 2):S125–S134

    PubMed  Google Scholar 

  • Satoh T, Kaziro Y (1992) Ras in signal transduction. Semin Cancer Biol 3:169–177

    PubMed  CAS  Google Scholar 

  • Schluter V, Meyer M, Hofschneider PH, Koshy R, Caselmann WH (1994) Integrated hepatitis B virus X and 3′ truncated preS/S sequences derived from human hepatomas encode functionally active transactivators. Oncogene 9(11):3335–3344

    PubMed  CAS  Google Scholar 

  • Seeger C, Mason WS (2000) Hepatitis B virus biology. Microbiol Mol Biol Rev 64(1):51–68

    PubMed  CAS  Google Scholar 

  • Seki S, Sakaguchi H, Kitada T, Tamori A, Takeda T, Kawada N, Habu D, Nakatani K, Nishiguchi S, Shiomi S (2000) Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study. Clin Cancer Res 6(9):3469–3473

    PubMed  CAS  Google Scholar 

  • Sherman M (2001) Surveillance for hepatocellular carcinoma. Semin Oncol 28(5):450–459

    PubMed  CAS  Google Scholar 

  • Sherman M (2005) Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis 25(2):143–154

    PubMed  Google Scholar 

  • Summers J, Mason WS (1982) Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29:403–415

    PubMed  CAS  Google Scholar 

  • Summers J, Mason WS (2004) Residual integrated viral DNA after hepadnavirus clearance by nucleoside analog therapy. Proc Natl Acad Sci USA 101(2):638–640

    PubMed  CAS  Google Scholar 

  • Tanaka N, Moriya K, Kiyosawa K, Koike K, Gonzalez FJ, Aoyama T (2008) PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice. J Clin Invest 118(2):683–694

    PubMed  Google Scholar 

  • Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, Ross JA, Liu W (2002) Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene 21(31):4863–4871

    PubMed  CAS  Google Scholar 

  • Tellinghuisen TL, Evans MJ, von Hahn T, You S, Rice CM (2007) Studying hepatitis C virus: making the best of a bad virus. J Virol 81(17):8853–8867

    PubMed  CAS  Google Scholar 

  • Tsai WL, Chung RT (2010) Viral hepatocarcinogenesis. Oncogene 29(16):2309–2324

    PubMed  CAS  Google Scholar 

  • Tuttleman JS, Pourcel C, Summers J (1986) Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 47:451–460

    PubMed  CAS  Google Scholar 

  • Wang J, Chenivesse X, Henglein B, Brechot C (1990) Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature 343(6258):555–557

    PubMed  CAS  Google Scholar 

  • Wright LM, Kreikemeier JT, Fimmel CJ (2007) A concise review of serum markers for hepatocellular cancer. Cancer Detect Prev 31(1):35–44

    PubMed  CAS  Google Scholar 

  • Wu TT, Coates L, Aldrich CE, Summers J, Mason WS (1990) In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. Virology 175(1):255–261

    PubMed  CAS  Google Scholar 

  • Xu Z, Jensen G, Yen TS (1997) Activation of hepatitis B virus S promoter by the viral large surface protein via induction of stress in the endoplasmic reticulum. J Virol 71(10):7387–7392

    PubMed  CAS  Google Scholar 

  • Yang W, Summers J (1999) Integration of hepadnavirus DNA in infected liver: evidence for a linear precursor. J Virol 73(12):9710–9717

    PubMed  CAS  Google Scholar 

  • Yoshida T, Hisamoto T, Akiba J, Koga H, Nakamura K, Tokunaga Y, Hanada S, Kumemura H, Maeyama M, Harada M, Ogata H, Yano H, Kojiro M, Ueno T, Yoshimura A, Sata M (2006) Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors. Oncogene 25(45):6056–6066

    PubMed  CAS  Google Scholar 

  • Yuen MF, Seto WK, Chow DH, Tsui K, Wong DK, Ngai VW, Wong BC, Fung J, Yuen JC, Lai CL (2007) Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease. Antivir Ther 12(8):1295–1303

    PubMed  CAS  Google Scholar 

  • Zhang YY, Zhang BH, Theele D, Litwin S, Toll E, Summers J (2003) Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver. Proc Natl Acad Sci USA 100(21):12372–12377

    PubMed  CAS  Google Scholar 

  • Zhang H, Zhai Y, Hu Z, Wu C, Qian J, Jia W, Ma F, Huang W, Yu L, Yue W, Wang Z, Li P, Zhang Y, Liang R, Wei Z, Cui Y, Xie W, Cai M, Yu X, Yuan Y, Xia X, Zhang X, Yang H, Qiu W, Yang J, Gong F, Chen M, Shen H, Lin D, Zeng YX, He F, Zhou G (2010) Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet 42(9):755–758

    PubMed  CAS  Google Scholar 

  • Zoulim F (2005) New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA. J Hepatol 42(3):302–308

    PubMed  Google Scholar 

  • Zoulim F, Seeger C (1994) Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol 68:2026–2030

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Ms. Erica Litschi for help in manuscript and figure preparation. The authors acknowledge support from National Cancer Institute and National Institute of Allergy and Infectious Diseases, and the Hepatitis B Foundation and The Commonwealth of Pennsylvania.

Author information

Authors and Affiliations

  1. Department of Microbiology and Immunology, Drexel University College of Medicine, Pennsylvania Biotechnology Center, Doylestown, PA, USA

    Timothy M. Block, Jinhong Chang & Ju-Tao Guo

  2. Hepatitis B Foundation, Pennsylvania Biotechnology Center, Doylestown, PA, USA

    Timothy M. Block

Authors
  1. Timothy M. Block
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jinhong Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ju-Tao Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Timothy M. Block .

Editor information

Editors and Affiliations

  1. Perelman School of Medicine, University of Pennsylvania, Hamilton Walk 3610, Philadelphia, 19104, Pennsylvania, USA

    Erle S. Robertson

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Block, T.M., Chang, J., Guo, JT. (2012). Overview of Hepatitis Viruses and Cancer. In: Robertson, E. (eds) Cancer Associated Viruses. Current Cancer Research. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-0016-5_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-0016-5_21

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-9999-3

  • Online ISBN: 978-1-4614-0016-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation